Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilja Spellmann

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Opinion in Psychiatry|February 7, 2007
Pharmacogenetics of antipsychotics: useful for the clinician?Brigitta Bondy, Ilja Spellmann
MMW Fortschritte Der Medizin|August 30, 2007
[Schizophrenic patients in the family practice]Michael Riedel, Ilja Spellmann, Norbert Müller, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
Quetiapine in the treatment of schizophrenia and related disordersMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Psychiatric Services (Washington, D.C.)|April 2, 2014
Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disordersJohannes Hamann, Marie-Luise Lipp, Sarah Christ-Zapp, et al.
Expert Opinion on Drug Safety|May 22, 2010
Safety evaluation of zotepine for the treatment of schizophreniaMichael Riedel, Richard Musil, Florian Seemüller, et al.
Journal of Psychiatric Research|January 26, 2006
Decreased T cellular immune response in schizophrenic patientsMichael Riedel, Ilja Spellmann, Markus J Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2018
Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patientsSophie K Kirchner, Selen Ozkan, Richard Musil, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 11, 2005
IL-2 and IL-4 polymorphisms as candidate genes in schizophreniaMarkus J Schwarz, Holger Krönig, Michael Riedel, et al.
Pharmacopsychiatry|September 21, 2018
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled StudyRebecca Schennach, Michael Riedel, Ilja Spellmann, et al.
Journal of Psychiatric Research|January 15, 2008
SNAP-25 gene polymorphisms and weight gain in schizophrenic patientsRichard Musil, Ilja Spellmann, Michael Riedel, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Opinion in Psychiatry|February 7, 2007
Pharmacogenetics of antipsychotics: useful for the clinician?Brigitta Bondy, Ilja Spellmann
MMW Fortschritte Der Medizin|August 30, 2007
[Schizophrenic patients in the family practice]Michael Riedel, Ilja Spellmann, Norbert Müller, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
Quetiapine in the treatment of schizophrenia and related disordersMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Psychiatric Services (Washington, D.C.)|April 2, 2014
Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disordersJohannes Hamann, Marie-Luise Lipp, Sarah Christ-Zapp, et al.
Expert Opinion on Drug Safety|May 22, 2010
Safety evaluation of zotepine for the treatment of schizophreniaMichael Riedel, Richard Musil, Florian Seemüller, et al.
Journal of Psychiatric Research|January 26, 2006
Decreased T cellular immune response in schizophrenic patientsMichael Riedel, Ilja Spellmann, Markus J Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2018
Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patientsSophie K Kirchner, Selen Ozkan, Richard Musil, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 11, 2005
IL-2 and IL-4 polymorphisms as candidate genes in schizophreniaMarkus J Schwarz, Holger Krönig, Michael Riedel, et al.
Pharmacopsychiatry|September 21, 2018
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled StudyRebecca Schennach, Michael Riedel, Ilja Spellmann, et al.
Journal of Psychiatric Research|January 15, 2008
SNAP-25 gene polymorphisms and weight gain in schizophrenic patientsRichard Musil, Ilja Spellmann, Michael Riedel, et al.
Pageof 4